Table of Contents Table of Contents
Previous Page  986 / 1851 Next Page
Information
Show Menu
Previous Page 986 / 1851 Next Page
Page Background

SWOG 0023:

Decreased OS for patients receiving maintenance Gefitinib

Kelly K, et al. JCO 2008;26

Decreased OS was a result of tumor progression and not Gefitinib toxicity